A huge congratulations to COE clinician-scientist Dr. Katherine Cummins on this accomplishment. #WomeninScience

September is #BloodCancerAwarenessMonth. The Peter Mac CoE in Cellular Immunotherapy is committed to ongoing research and translation of life-saving CAR-T and other cellular immunotherapies for #BloodCancer Leukaemia Foundation

Peter Mac’s Centre of Excellence in Cellular Immunotherapy has established a new dedicated laboratory to rapidly progress its cell-based immunotherapy breakthroughs into clinical trials. The CoE CIT Translation Laboratory (CoE-Lab) is lead by A/Prof Jane Oliaro, Chief Scientist

Peter Mac's CoE CIT is excited to announce our new partnership with CellVec "This partnership with CellVec will underpin and enable a pipeline of high-potential research focused on developing the next generation of immunotherapies" - CoECIT director, Prof Simon Harrison

Eight Peter Mac scientists who are pioneering new treatments and advancing understanding of #cancer have secured more than $9.6 million in funding from NHMRC. Big congratulations all! Click the link to read more about our scientists and their #research petermac.org/news/latest-nh…

A big congratulations to these PeterMac researchers awarded NHMRC grants Peter Mac Research

The RM Catalyst recently published two reports revealing Australia's potential to become a global leader in the #regenerativemedicine sector from both a manufacturing and clinical trial perspective. Click here to read: ausbiotech.org/news/australia… #cellandgenetherapies AusBiotech

Peter Mac is pleased to announce that Professors Sherene Loi, MD, Grant McArthur, Ben Solomon and Phillip Darcy have all been named in the annual Highly Cited Researchers List for 2021 for their exceptional citation impact in their field #highlycited2021 bit.ly/3DuY8Hi

Great article Leukaemia Foundation and Deputy Clinical Director of the CoE CIT, Michael Dickinson Thanks for sharing Cell Therapies Pty Ltd #CART #celltherapy #cellularimmunotherapy

#ash21 late breaking abstracts are out bit.ly/3xhSaqB Definitely some food for thought with #polarix and #belinda abstracts now available #lymsm

#CARTcell on our journal: "While acknowledging that there are no approved CAR T-cell therapies for CLL yet, this comprehensive review explores novel targets for CAR T-cell therapy in CLL and highlights the promising results of CAR T-cell trials to date." astctjournal.org/article/S2666-…

Congrats to all involved in this study #kymriah #CARTtherapy #cellularimmunotherapy

Building international partnerships with leaders in Cellular Immunotherapy across time zones this morning with U of Penn and Peter Mac Cancer Centre experts sharing up-to-the-minute research to improve treatments for cancer patients across the world. Peter Mac CoE in Cellular Immunotherapy

Peter Mac CoE in Cellular Immunotherapy Chief Scientist A/Prof Jane Oliaro highlighting the goals of the COE at the PeterMac Research Retreat Peter Mac Research

Today is #InternationalClinicalTrialsDay. It takes a huge team of people to make clinical trials happen, thank you to everyone involved in the journey. Read one of our amazing clinical trial stories here: petermac.org/news/new-cance… #CTD2022 #clincialtrialsday Peter Mac Research

Congratulations to CoECIT chief scientist A/Prof Jane Oliaro for receiving funding from the Leukaemia Foundation, Snowdome Foundation and LLS for her project “Making CAR T-cell therapy more effective for aggressive lymphoma and multiple myeloma” leukaemia.org.au/media/internat….

Each year we join forces with 伊藤佑愛 & Snowdome Foundation to identify & fund new translational research projects. Congratulations Assoc. Professor Jane Oliaro Peter Mac Research and Professor Richard Lock Childrens Cancer Institute! Learn more: rebrand.ly/translational-…

Congratulations to A/Prof Jane Oliaro of Peter Mac Research and Peter Mac CoE in Cellular Immunotherapy and Prof Richard Lock of Childrens Cancer Institute, the latest recipients of the 伊藤佑愛, Snowdome and Leukaemia Foundation. Australian translational research programme into blood cancer. 🔗ow.ly/9KTE50JFl08

Today we welcomed Kassem Younes, General Manager of Middle East, Türkiye and Africa for Global Victoria who facilitate trade and investment between Victoria and the Middle East and Africa. Ricky Johnstone led a tour of his lab plus two of our key areas Peter Mac CoE in Cellular Immunotherapy and ProsTIC

Great to see our consensus guidelines on CD20x3 #bispecific safety management in a nice PDF @bloodjournal buff.ly/3UnRDRn. Hopefully a useful resource for the roll out of these potent drugs #lymsm #glofitamab #Epcoritamab #mosunetuzumab